Minimal residual disease in chronic myelogenous leukemia: results of RT-PCR detection of BCR-ABL transcripts
NCP Cross, A Hochhaus - Leukemia and Lymphoma: Detection of Minimal …, 2003 - Springer
The Degrees of treatment-induced tumor load reduction is an important prognostic factor for
patients with CML. Response to treatment may be determined at three levels:(1) …
patients with CML. Response to treatment may be determined at three levels:(1) …
APPLICATION OF A NEW MOLECULAR APPROACH BASED ON NEXT GENERATION SEQUENCING TO MONITOR THE CHIMERISM POST ALLOGENEIC HSCT
M Aloisio - 2019 - arts.units.it
After the hematopoietic stem cell transplant, the chimerism analysis is routinely evaluated to
monitor donor immune system engraftment. Today, the most common genetic diagnostic …
monitor donor immune system engraftment. Today, the most common genetic diagnostic …
Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF
U Siebolts, J Thiele, T Zander… - Oncology …, 2008 - spandidos-publications.com
Since decades myeloablation followed by allogeneic stem cell transplantation offered the
only opportunity to cure leukemia patients and only recently the development of STI571 …
only opportunity to cure leukemia patients and only recently the development of STI571 …
Targeting autophagy in chronic myeloid leukemia through inhibition of the core autophagy protein ATG4B
VL Porter - 2018 - open.library.ubc.ca
Abstract Treatment of chronic myeloid leukemia (CML) targets the BCR-ABL1 fusion
oncoprotein that characterizes its pathogenesis using tyrosine kinase inhibitors (TKIs); …
oncoprotein that characterizes its pathogenesis using tyrosine kinase inhibitors (TKIs); …
[PDF][PDF] Research Article Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients …
M Aljurf, H Abalkhail, A Alseraihy, SY Mohamed… - 2016 - academia.edu
Background. We studied DNA chimerism in cell-free DNA (cfDNA) in patients treated with
HSCT. Methods. Chimerism analysis was performed on CD3+ cells, polymorphonuclear …
HSCT. Methods. Chimerism analysis was performed on CD3+ cells, polymorphonuclear …
[PDF][PDF] CRUCIAL ROLE OF TIMING OF DONOR LYMPHOCYTE INFUSION IN
INM GRAFT-VERSUS-LEUKEMIA RESPONSES… - researchgate.net
ABSTRACT A murine model of minor histocompatibility antigen-mismatched bone marrow
transplantation (BMT) was used to study the role of timing of donor lymphocyte infusion (DLI) …
transplantation (BMT) was used to study the role of timing of donor lymphocyte infusion (DLI) …
[PDF][PDF] Increasing Chimerism after Allogeneic Stem Cell Transplantation Is Associated with Longer Survival Time
H Jakher, P Stafford, M Zope, EJ Shpall… - Biol Blood Marrow …, 2014 - cyberleninka.org
abstract Donor chimerism after allogeneic stem cell transplantation (allo-SCT) is commonly
used to predict overall survival (OS) and disease-free survival (DFS). Because chimerism is …
used to predict overall survival (OS) and disease-free survival (DFS). Because chimerism is …
Outcome After Allogeneic Stem Cell Transplantation with Special Reference to Non-Malignant Disorders, Chimerism and Graft Cell Composition
P Svenberg - 2018 - search.proquest.com
The outcome for patients undergoing allogeneic stem cell transplantation (HSCT), a
treatment for several severe malignant and non-malignant disorders with hematopoietic …
treatment for several severe malignant and non-malignant disorders with hematopoietic …
Interaction of Human Polyomavirus JC with cells of the hematopoietic system in the periphery
S Sbiera - 2012 - opus.bibliothek.uni-wuerzburg.de
Primary contact with human polyomaviruses is followed by lifelong asymptomatic
persistence of viral DNA. Under severe immunosuppression JCV activation may lead to …
persistence of viral DNA. Under severe immunosuppression JCV activation may lead to …